相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Structure-based inhibitors of tau aggregation
P. M. Seidler et al.
NATURE CHEMISTRY (2018)
Hybrid Multifunctional Modulators Inhibit Multifaceted Aβ Toxicity and Prevent Mitochondrial Damage
K. Rajasekhar et al.
ACS CHEMICAL NEUROSCIENCE (2018)
Shedding light on tau protein aggregation: the progress in developing highly selective fluorophores
Peter Verwilst et al.
CHEMICAL SOCIETY REVIEWS (2018)
High performance plasma amyloid-β biomarkers for Alzheimer's disease
Akinori Nakamura et al.
NATURE (2018)
IMMUNOTHERAPY Immune-modified response criteria an iterative learning process?
Patrick A. Ott
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Safety, tolerability and immunogenicity of an active anti-Aβ40 vaccine (ABvac40) in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase I trial
Ana-Maria Lacosta et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
Mechanism of NMDA receptor channel block by MK-801 and memantine
Xianqiang Song et al.
NATURE (2018)
Role of Glutamate and NMDA Receptors in Alzheimer's Disease
Rui Wang et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Glutaminyl Cyclase Inhibitor PQ912 Improves Cognition in Mouse Models of Alzheimer's Disease-Studies on Relation to Effective Target Occupancy
Torsten Hoffmann et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
Analyzing Amyloid Beta Aggregates with a Combinatorial Fluorescent Molecular Sensor
Joydev Hatai et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2017)
β-Hairpin mimics containing a piperidine-pyrrolidine scaffold modulate the β-amyloid aggregation process preserving the monomer species
S. Pellegrino et al.
CHEMICAL SCIENCE (2017)
Two decades of new drug discovery and development for Alzheimer's disease
Zhidong Liu et al.
RSC ADVANCES (2017)
Alzheimer's Disease and the Amyloid-β Peptide
M. Paul Murphy et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Aβ plaque-selective NIR fluorescence probe to differentiate Alzheimer's disease from tauopathies
K. Rajasekhar et al.
BIOSENSORS & BIOELECTRONICS (2017)
Drug candidates in clinical trials for Alzheimer's disease
Shih-Ya Hung et al.
JOURNAL OF BIOMEDICAL SCIENCE (2017)
A Review of Fluid Biomarkers for Alzheimer's Disease: Moving from CSF to Blood
Kaj Blennow
NEUROLOGY AND THERAPY (2017)
Amyloid Beta and Tau as Alzheimer's Disease Blood Biomarkers: Promise From New Technologies
Lih-Fen Lue et al.
NEUROLOGY AND THERAPY (2017)
Towards an understanding of amyloid-β oligomers: characterization, toxicity mechanisms, and inhibitors
Shin Jung C. Lee et al.
CHEMICAL SOCIETY REVIEWS (2017)
The Role of Cdk5 in Alzheimer's Disease
Shu-Lei Liu et al.
MOLECULAR NEUROBIOLOGY (2016)
Natural Tripeptide-Based Inhibitor of Multifaceted Amyloid β Toxicity
K. Rajasekhar et al.
ACS CHEMICAL NEUROSCIENCE (2016)
Advances in development of fluorescent probes for detecting amyloid-β aggregates
Ming-ming Xu et al.
ACTA PHARMACOLOGICA SINICA (2016)
RESULTS FROM A FIRST-IN-HUMAN STUDY WITH THE BACE INHIBITOR CNP520
Mike Ufer et al.
Alzheimers & Dementia (2016)
CLINICAL TRIAL DESIGN OF CREAD: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP PHASE 3 STUDY TO EVALUATE CRENEZUMAB TREATMENT IN PATIENTS WITH PRODROMAL-TO-MILD ALZHEIMER’S DISEASE
Thomas Blaettler et al.
Alzheimers & Dementia (2016)
Histidine-Rich Oligopeptides To Lessen Copper-Mediated Amyloid-β Toxicity
Ana B. Caballero et al.
CHEMISTRY-A EUROPEAN JOURNAL (2016)
The Anti-Inflammatory Role of Minocycline in Alzheimer's Disease
J. Budni et al.
CURRENT ALZHEIMER RESEARCH (2016)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
AZD3293: A Novel, Orally Active BACE1 Inhibitor with High Potency and Permeability and Markedly Slow Off-Rate Kinetics
Susanna Eketjall et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Designed Glycopeptidomimetics Disrupt Protein-Protein Interactions Mediating Amyloid β-Peptide Aggregation and Restore Neuroblastoma Cell Viability
Julia Kaffy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Small-Animal PET Imaging of Tau Pathology with 18F-THK5117 in 2 Transgenic Mouse Models
Matthias Brendel et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
Bob Olsson et al.
LANCET NEUROLOGY (2016)
The antibody aducanumab reduces Aβ plaques in Alzheimer's disease
Jeff Sevigny et al.
NATURE (2016)
The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer's disease patients
Matthew E. Kennedy et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Stimuli-responsive colorimetric and NIR fluorescence combination probe for selective reporting of cellular hydrogen peroxide
Nagarjun Narayanaswamy et al.
CHEMICAL SCIENCE (2016)
A High Affinity Red Fluorescence and Colorimetric Probe for Amyloid β Aggregates
K. Rajasekhar et al.
SCIENTIFIC REPORTS (2016)
Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease
Francesco Panza et al.
BIOMED RESEARCH INTERNATIONAL (2016)
Comparison of New Tau PET-Tracer Candidates With [18F]T808 and [18F]T807
Lieven Declercq et al.
MOLECULAR IMAGING (2016)
Stepping closer to treating Alzheimer's disease patients with BACE1 inhibitor drugs
Riqiang Yan
TRANSLATIONAL NEURODEGENERATION (2016)
Structure of Crenezumab Complex with Aβ Shows Loss of β-Hairpin
Mark Ultsch et al.
SCIENTIFIC REPORTS (2016)
Regulation of Copper and Iron Homeostasis by Metal Chelators: A Possible Chemotherapy for Alzheimer's Disease
Anne Robert et al.
ACCOUNTS OF CHEMICAL RESEARCH (2015)
Targeting Human Central Nervous System Protein Kinases: An Isoform Selective p38αMAPK Inhibitor That Attenuates Disease Progression in Alzheimer's Disease Mouse Models
Saktimayee M. Roy et al.
ACS CHEMICAL NEUROSCIENCE (2015)
Tabersonine Inhibits Amyloid Fibril Formation and Cytotoxicity of Aβ(1-42)
Tianhan Kai et al.
ACS CHEMICAL NEUROSCIENCE (2015)
Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study
Osama Sabri et al.
ALZHEIMERS & DEMENTIA (2015)
Inhibition of Alzheimer's amyloid-β peptide aggregation and its disruption by a conformationally restricted α/β hybrid peptide
Ashim Paul et al.
CHEMICAL COMMUNICATIONS (2015)
Function and toxicity of amyloid beta and recent therapeutic interventions targeting amyloid beta in Alzheimer's disease
K. Rajasekhar et al.
CHEMICAL COMMUNICATIONS (2015)
Imaging of beta-amyloid plaques by near infrared fluorescent tracers: a new frontier for chemical neuroscience
Matteo Staderini et al.
CHEMICAL SOCIETY REVIEWS (2015)
Human secreted tau increases amyloid-beta production
Jessica Bright et al.
NEUROBIOLOGY OF AGING (2015)
Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial
Joseph Butchart et al.
NEUROLOGY (2015)
Autophagy in Alzheimer's disease
Ameneh Zare-shahabadi et al.
REVIEWS IN THE NEUROSCIENCES (2015)
Novel PET/SPECT Probes for Imaging of Tau in Alzheimer’s Disease
Hiroyuki Watanabe et al.
TheScientificWorldJOURNAL (2015)
Novel PET/SPECT Probes for Imaging of Tau in Alzheimer’s Disease
Hiroyuki Watanabe et al.
Scientific World Journal (2015)
Oxidative stress: a concept in redox biology and medicine
Helmut Sies
REDOX BIOLOGY (2015)
A Food and Drug Administration-approved Asthma Therapeutic Agent Impacts Amyloid β in the Brain in a Transgenic Model of Alzheimer Disease
Yukiko Hori et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Promoting Autophagic Clearance: Viable Therapeutic Targets in Alzheimer's Disease
Lauren G. Friedman et al.
NEUROTHERAPEUTICS (2015)
Rationally Designed Peptidomimetic Modulators of Aβ Toxicity in Alzheimer's Disease
K. Rajasekhar et al.
SCIENTIFIC REPORTS (2015)
Brazilin inhibits amyloid β-protein fibrillogenesis, remodels amyloid fibrils and reduces amyloid cytotoxicity functional
Wen-Jie Du et al.
SCIENTIFIC REPORTS (2015)
Molecular basis for mid-region amyloid-β capture by leading Alzheimer's disease immunotherapies
Gabriela A. N. Crespi et al.
SCIENTIFIC REPORTS (2015)
Selective Brain-Targeted Antagonism of p38 MAPKα Reduces Hippocampal IL-1β Levels and Improves Morris Water Maze Performance in Aged Rats
John J. Alam
JOURNAL OF ALZHEIMERS DISEASE (2015)
Metal Ions and Intrinsically Disordered Proteins and Peptides: From Cu/Zn Amyloid-β to General Principles
Peter Faller et al.
ACCOUNTS OF CHEMICAL RESEARCH (2014)
The Ongoing Search for Small Molecules to Study Metal-Associated Amyloid-β Species in Alzheimer's Disease
Masha G. Savelieff et al.
ACCOUNTS OF CHEMICAL RESEARCH (2014)
Rationally Designed Peptoids Modulate Aggregation of Amyloid-Beta 40
J. Phillip Turner et al.
ACS CHEMICAL NEUROSCIENCE (2014)
Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET
Nobuyuki Okamura et al.
BRAIN (2014)
Peptidomimetics via modifications of amino acids and peptide bonds
Ilker Avan et al.
CHEMICAL SOCIETY REVIEWS (2014)
Biological metals and metal-targeting compounds in major neurodegenerative diseases
Kevin J. Barnham et al.
CHEMICAL SOCIETY REVIEWS (2014)
Structure and Mechanism of Action of Tau Aggregation Inhibitors
Katryna Cisek et al.
CURRENT ALZHEIMER RESEARCH (2014)
Biomarkers in Alzheimer's Disease Analysis by Mass Spectrometry-Based Proteomics
Yahui Liu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
A new roadmap for drug development for Alzheimer's disease
Robert E. Becker et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Microglial priming in neurodegenerative disease
V. Hugh Perry et al.
NATURE REVIEWS NEUROLOGY (2014)
First-in-man tau vaccine targeting structural determinants essential for pathological tau-tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer's disease model
Eva Kontsekova et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
Crystal structure reveals conservation of amyloid-beta conformation recognized by 3D6 following humanization to bapineuzumab
Hadar Feinberg et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
Synthesis of Hybrid Cyclic Peptoids and Identification of Autophagy Enhancer
Kolla Rajasekhar et al.
CHEMPLUSCHEM (2014)
Vaccination against Alzheimer disease An update on future strategies
Antonia Fettelschoss et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Amyloid-β and Tau The Trigger and Bullet in Alzheimer Disease Pathogenesis
George S. Bloom
JAMA NEUROLOGY (2014)
Untangling Amyloid-β, Tau, and Metals in Alzheimer's Disease
MG Savelieff et al.
ACS CHEMICAL BIOLOGY (2013)
A first-in-human study of BAN2401, a novel monoclonal antibody against beta-amyloid protofibrils
Robert Lai et al.
Alzheimers & Dementia (2013)
The global prevalence of dementia: A systematic review and metaanalysis
Martin Prince et al.
ALZHEIMERS & DEMENTIA (2013)
Pyroglutamate-3 Amyloid-β Deposition in the Brains of Humans, Non-Human Primates, Canines, and Alzheimer Disease-Like Transgenic Mouse Models
Jeffrey L. Frost et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Design, Synthesis, and Evaluation of Multitarget-Directed Resveratrol Derivatives for the Treatment of Alzheimer's Disease
Chuanjun Lu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Immunogenicity, Efficacy, Safety, and Mechanism of Action of Epitope Vaccine (Lu AF20513) for Alzheimer's Disease: Prelude to a Clinical Trial
Hayk Davtyan et al.
JOURNAL OF NEUROSCIENCE (2013)
Anti-Tau Antibodies that Block Tau Aggregate Seeding In Vitro Markedly Decrease Pathology and Improve Cognition In Vivo
Kiran Yanamandra et al.
NEURON (2013)
Natural Compounds May Open New Routes to Treatment of Amyloid Diseases
Jan Bieschke
NEUROTHERAPEUTICS (2013)
A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
Rachelle S. Doody et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Efficacy and Safety of A Liposome-Based Vaccine against Protein Tau, Assessed in Tau.P301L Mice That Model Tauopathy
Clara Theunis et al.
PLOS ONE (2013)
Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism
Samuel I. A. Cohen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Recent developments of protein kinase inhibitors as potential AD therapeutics
Volkmar Tell et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2013)
Plasma Amyloid-β as a Predictor of Dementia and Cognitive Decline A Systematic Review and Meta-analysis
Alain Koyama et al.
ARCHIVES OF NEUROLOGY (2012)
Mechanism of Amyloid Removal in Patients With Alzheimer Disease Treated With Gantenerumab
Susanne Ostrowitzki et al.
ARCHIVES OF NEUROLOGY (2012)
Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease
Vladimir Coric et al.
ARCHIVES OF NEUROLOGY (2012)
The N-Methylated Peptide SEN304 Powerfully Inhibits Aβ(1-42) Toxicity by Perturbing Oligomer Formation
Hozefa Amijee et al.
BIOCHEMISTRY (2012)
PET amyloid-beta imaging in preclinical Alzheimer's disease
Andrei G. Vlassenko et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2012)
Alzheimer Mechanisms and Therapeutic Strategies
Yadong Huang et al.
CELL (2012)
A differentially selective sensor with fluorescence turn-on response to Zn2+ and dual-mode ratiometric response to Al3+ in aqueous media
Debabrata Maity et al.
CHEMICAL COMMUNICATIONS (2012)
The Amyloid Beta Peptide: A Chemist's Perspective. Role in Alzheimer's and Fibrillization
I. W. Hamley
CHEMICAL REVIEWS (2012)
Misfolded proteins in Alzheimer's disease and type II diabetes
Alaina S. DeToma et al.
CHEMICAL SOCIETY REVIEWS (2012)
Inhibition of Cu-Amyloid-β by using Bifunctional Peptides with β-Sheet Breaker and Chelator Moieties
Madeleine Jensen et al.
CHEMISTRY-A EUROPEAN JOURNAL (2012)
New developments on the role of NMDA receptors in Alzheimer's disease
Roberto Malinow
CURRENT OPINION IN NEUROBIOLOGY (2012)
Evidence for Irreversible Inhibition of Glycogen Synthase Kinase-3β by Tideglusib
Juan Manuel Dominguez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Liberation of Copper from Amyloid Plaques: Making a Risk Factor Useful for Alzheimer's Disease Treatment
Jie Geng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Bifunctional Compounds for Controlling Metal-Mediated Aggregation of the Aβ42 Peptide
Anuj K. Sharma et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Small-molecule conversion of toxic oligomers to nontoxic β-sheet-rich amyloid fibrils
Jan Bieschke et al.
NATURE CHEMICAL BIOLOGY (2012)
Antioxidant Therapies for Alzheimer's Disease
Ye Feng et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2012)
Mitochondria-Specific Accumulation of Amyloid β Induces Mitochondrial Dysfunction Leading to Apoptotic Cell Death
Moon-Yong Cha et al.
PLOS ONE (2012)
Inflammation in Alzheimer Disease-A Brief Review of the Basic Science and Clinical Literature
Tony Wyss-Coray et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Brain Imaging in Alzheimer Disease
Keith A. Johnson et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Active DNA Aβ42 vaccination as immunotherapy for alzheimer disease
Doris Lambracht-Washington et al.
TRANSLATIONAL NEUROSCIENCE (2012)
PF-04494700, an Oral Inhibitor of Receptor for Advanced Glycation End Products (RAGE), in Alzheimer Disease
Marwan N. Sabbagh et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2011)
Visible-Near-Infrared and Fluorescent Copper Sensors Based on Julolidine Conjugates: Selective Detection and Fluorescence Imaging in Living Cells
Debabrata Maity et al.
CHEMISTRY-A EUROPEAN JOURNAL (2011)
The Alzheimer's therapeutic PBT2 promotes amyloid-β degradation and GSK3 phosphorylation via a metal chaperone activity
Peter J. Crouch et al.
JOURNAL OF NEUROCHEMISTRY (2011)
The Second-Generation Active Aβ Immunotherapy CAD106 Reduces Amyloid Accumulation in APP Transgenic Mice While Minimizing Potential Side Effects
Christoph Wiessner et al.
JOURNAL OF NEUROSCIENCE (2011)
Oleuropein and derivatives from olives as Tau aggregation inhibitors
Anthony Daccache et al.
NEUROCHEMISTRY INTERNATIONAL (2011)
A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease
S. Salloway et al.
NEUROLOGY (2011)
Proinflammatory cytokines, sickness behavior, and Alzheimer disease
C. Holmes et al.
NEUROLOGY (2011)
In-vivo histamine H3 receptor antagonism activates cellular signaling suggestive of symptomatic and disease modifying efficacy in Alzheimer's disease
R. Scott Bitner et al.
NEUROPHARMACOLOGY (2011)
Multi-Method Analysis of MRI Images in Early Diagnostics of Alzheimer's Disease
Robin Wolz et al.
PLOS ONE (2011)
Mitochondrial dysfunction - the beginning of the end in Alzheimer's disease? Separate and synergistic modes of tau and amyloid-beta toxicity
Anne Eckert et al.
ALZHEIMERS RESEARCH & THERAPY (2011)
Anatomy and physiology of cerebrospinal fluid
L. Sakka et al.
EUROPEAN ANNALS OF OTORHINOLARYNGOLOGY-HEAD AND NECK DISEASES (2011)
The Revitalized Tau Hypothesis on Alzheimer's Disease
Ricardo B. Maccioni et al.
ARCHIVES OF MEDICAL RESEARCH (2010)
Pyrrolidine constrained bipyridyl-dansyl click fluoroionophore as selective Al3+ sensor
Debabrata Maity et al.
CHEMICAL COMMUNICATIONS (2010)
Tau in Alzheimer Disease and Related Tauopathies
K. Iqbal et al.
CURRENT ALZHEIMER RESEARCH (2010)
Memogain is a Galantamine Pro-drug having Dramatically Reduced Adverse Effects and Enhanced Efficacy
Alfred Maelicke et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2010)
In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand F-18-AV-45 (Flobetapir F 18)
Dean F. Wong et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Autophagy: cellular and molecular mechanisms
Danielle Glick et al.
JOURNAL OF PATHOLOGY (2010)
Methylene blue fails to inhibit Tau and polyglutamine protein dependent toxicity in zebrafish
Frauke van Bebber et al.
NEUROBIOLOGY OF DISEASE (2010)
Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy
Elina Zotova et al.
ALZHEIMERS RESEARCH & THERAPY (2010)
NIC5-15 as a treatment for Alzheimer's: Safety, pharmacokinetics and clinical variables
Hillel Grossman et al.
Alzheimers & Dementia (2009)
Receptor for advanced glycation end products: its role in Alzheimer's disease and other neurological diseases
Lih-Fen Lue et al.
FUTURE NEUROLOGY (2009)
Restraining tumor necrosis factor-alpha by thalidomide prevents the Amyloid beta-induced impairment of recognition memory in mice
Tursun Alkam et al.
BEHAVIOURAL BRAIN RESEARCH (2008)
Beta-Secretase: Structure, Function, and Evolution
Chitra Venugopal et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2008)
Peptidomimetics, a synthetic tool of drug discovery
Josef Vagner et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2008)
Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease-like pathology
Stephan Schilling et al.
NATURE MEDICINE (2008)
Therapeutics for Alzheimer's disease based on the Metal Hypothesis
Ashley I. Bush et al.
NEUROTHERAPEUTICS (2008)
Efficient inhibition of the Alzheimer's disease β-secretase by membrane targeting
Lawrence Rajendran et al.
SCIENCE (2008)
Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice
Andreas Muhs et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B
WE Klunk et al.
ANNALS OF NEUROLOGY (2004)
Protein aggregation and neurodegenerative disease
CA Ross et al.
NATURE MEDICINE (2004)
Inhibition of amyloid fibril formation by peptide analogues modified with alpha-aminoisobutyric acid
S Gilead et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2004)
The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: Recent challenges and their implications for novel drug development
AV Terry et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Treatment with a copper-zinc chelator markedly and rapidly inhibits β-amyloid accumulation in Alzheimer's disease transgenic mice
RA Cherny et al.
NEURON (2001)
Tau protein isoforms, phosphorylation and role in neurodegenerative disorders
L Buée et al.
BRAIN RESEARCH REVIEWS (2000)
Inflammation and Alzheimer's disease
H Akiyama et al.
NEUROBIOLOGY OF AGING (2000)
分享论文
